0001104659-17-031086.txt : 20170509 0001104659-17-031086.hdr.sgml : 20170509 20170509140127 ACCESSION NUMBER: 0001104659-17-031086 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170505 FILED AS OF DATE: 20170509 DATE AS OF CHANGE: 20170509 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nivalis Therapeutics, Inc. CENTRAL INDEX KEY: 0001626199 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208969493 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3122 STERLING CIRCLE, SUITE 200 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 720-945-7700 MAIL ADDRESS: STREET 1: 3122 STERLING CIRCLE, SUITE 200 CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: N30 Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20141121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TROHA JANICE CENTRAL INDEX KEY: 0001068894 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37449 FILM NUMBER: 17825732 MAIL ADDRESS: STREET 2: 6850 NORTH BROADWAY CITY: DENVER STATE: CO ZIP: 80221 4 1 a4.xml 4 X0306 4 2017-05-05 0 0001626199 Nivalis Therapeutics, Inc. NVLS 0001068894 TROHA JANICE C/O NIVALIS THERAPEUTICS, INC. PO BOX 18387 BOULDER CO 80308 0 1 0 0 Exec Vice President / COO Common Stock 2017-05-05 4 P 0 10000 2.34 A 10000 D The price recorded in Column 4 represents the actual price for the full block purchase. /s/ R. Michael Carruthers, Attorney-in-Fact 2017-05-09